StockData
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. (LEXX) stock

LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.18−0.23 (-5.22%)

Close on Nov 17, 2026Market cap $103.61MP/E –Yield –

Lexaria Bioscience enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Lexaria Bioscience's enterprise value was $110.98M on Nov 11, 2026, against $317.44M a year earlier. Over the last 5 years it ranged from $61.31M to $961.03M, with a median of $256.60M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$110.98M-37.9%
2025Dec 31, 2025$178.68M-70.7%
2024Dec 31, 2024$609.15M+306.5%
2023Dec 29, 2023$149.87M-29.7%
2022Dec 30, 2022$213.10M-36.2%
2021Dec 31, 2021$334.21M-0.3%
2020Dec 31, 2020$335.38M-25.6%
2019Dec 31, 2019$450.82M-57.1%
2018Dec 31, 2018$1.05B-38.9%
2017Dec 29, 2017$1.72B+622.2%
2016Dec 30, 2016$238.23M–

More Lexaria Bioscience figures

See a number that looks wrong?